These figures pool every individual call made by Stifel Nicolaus's analysts into a single sample — so a prolific analyst carries more weight than a low-volume one, exactly in proportion to the evidence available. All metrics are computed independently by 13Foresight from historical prices. Returns are measured in each stock's own trading currency, so for non-US listings the comparison against the S&P 500 does not account for currency moves — a US investor's dollar return would differ by however the exchange rate shifted.
| Analyst | Our Rank | Stars | Success | Avg Return | vs S&P | Calls |
|---|---|---|---|---|---|---|
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| J. Parker Lane | #261 | ★★★★★ | 63% | +7.0% | +4.9% | 99 |
| Mark Kelley | #276 | ★★★★★ | 70% | +22.5% | +9.8% | 33 |
| Thomas Stephan | #688 | ★★★★ | 60% | +2.6% | +1.9% | 52 |
| Peter McGoldrick | #722 | ★★★★ | 56% | +3.2% | +2.1% | 81 |
| Simon Yarmak | #762 | ★★★★ | 57% | +1.6% | +0.1% | 114 |
| Jonathan Block | #791 | ★★★★ | 55% | +6.1% | +3.9% | 71 |
| John Cahill | #828 | ★★★★ | 69% | +10.2% | -5.6% | 16 |
| Ingrid Rico | #874 | ★★★★ | 52% | +19.9% | +12.4% | 21 |
| Chris Wheaton | #993 | ★★★ | 64% | +18.8% | +1.8% | 14 |
| Daryl Young | #1009 | ★★★ | 57% | +1.2% | -1.7% | 47 |
| Suthan Sukumar | #1034 | ★★★ | 66% | +1.2% | -0.5% | 35 |
| Matthew Smith, CFA | #1051 | ★★★ | 57% | +0.9% | -0.8% | 74 |
| Mark Davies Jones | #1138 | ★★★ | 65% | +11.0% | -7.7% | 20 |
| Adam Farley | #1252 | ★★★ | 50% | +0.0% | -1.1% | 12 |
| Ian Gillies | #1278 | ★★★ | 57% | +8.1% | +2.5% | 91 |
| Brad Reback | #1316 | ★★★ | 53% | +5.6% | +0.9% | 96 |
| Dara Azar | #1417 | ★★★ | 42% | +2.3% | +2.4% | 19 |
| Erik Rasmussen | #1511 | ★★★ | 56% | -4.8% | -6.4% | 18 |
| W. Andrew Carter | #1670 | ★★★ | 56% | -1.0% | -3.6% | 86 |
| Steven Wieczynski | #1690 | ★★★ | 50% | -1.8% | -2.8% | 64 |
| Alex Thompson CFA | #1704 | ★★★ | 51% | +3.2% | +0.2% | 61 |
| Nathan Jones | #1763 | ★★★ | 46% | -0.7% | -1.8% | 168 |
| Jeffrey Stantial | #1885 | ★★★ | 46% | -1.4% | -2.7% | 65 |
| Justin Keywood | #1904 | ★★★ | 51% | -1.1% | -3.8% | 74 |
| Martin Landry | #2123 | ★★★ | 54% | -4.4% | -8.8% | 56 |
| Paul Matteis | #2132 | ★★★ | 49% | +6.0% | +2.8% | 107 |
| J. Bruce Chan | #2244 | ★★★ | 41% | -0.2% | -1.8% | 88 |
| David Deckelbaum | #2284 | ★★ | 40% | +7.2% | +1.7% | 58 |
| Cole McGill | #2332 | ★★ | 42% | +9.1% | +2.9% | 50 |
| Stephen Willey | #2353 | ★★ | 49% | -2.2% | -5.3% | 97 |
| Christian Glennie | #2356 | ★★ | 47% | +7.2% | -9.1% | 15 |
| Ralph M. Profiti | #2447 | ★★ | 46% | -2.9% | -6.6% | 118 |
| Greg MacDonald | #2539 | ★★ | 30% | -4.5% | -6.8% | 20 |
| James Condulis | #2559 | ★★ | 38% | -2.9% | -4.3% | 32 |
| Stephen Gengaro | #2615 | ★★ | 43% | +7.9% | +4.5% | 122 |
| Tore Svanberg | #2696 | ★★ | 39% | -4.9% | -5.6% | 96 |
| Charlie Campbell | #2699 | ★★ | 43% | -1.7% | -18.4% | 21 |
| Selman Akyol | #2736 | ★★ | 38% | -2.6% | -9.0% | 50 |
| Laura Prendergast | #2749 | ★★ | 40% | -7.1% | -8.4% | 40 |
| Brian Chin | #2832 | ★★ | 28% | +0.4% | -1.0% | 47 |
| Lars Kjellberg | #2857 | ★★ | 45% | -1.2% | -22.6% | 22 |
| Jonathan Siegmann CFA | #2877 | ★★ | 36% | -7.6% | -9.2% | 58 |
| Ruben Roy | #2898 | ★★ | 37% | -5.1% | -7.8% | 97 |
| Annabel Samimy | #2972 | ★ | 39% | -7.5% | -11.8% | 56 |
| Brian Brophy | #3126 | ★ | 25% | -12.2% | -13.5% | 56 |
| Madison Tapscott | — | — | 80% | +429.1% | +409.8% | 5 |
The 6 top-ranked analysts at Stifel Nicolaus, the firm's full 3- and 5-year track record, and firm-vs-firm rankings across Wall Street. Everything below the top 6, plus 1- and 2-year history, stays free — Pro is what keeps this independent research running and the servers paid for.
Upgrade to ProDisclaimer: Firm-level performance is calculated independently by 13Foresight by pooling the historical calls of analysts associated with this firm, measured against market prices. It may be incomplete or delayed, is for research purposes only, and is not investment advice.